115 related articles for article (PubMed ID: 26546727)
1. In silico and experimental validation of protein-protein interactions between PknI and Rv2159c from Mycobacterium tuberculosis.
Venkatesan A; Hassan S; Palaniyandi K; Narayanan S
J Mol Graph Model; 2015 Nov; 62():283-293. PubMed ID: 26546727
[TBL] [Abstract][Full Text] [Related]
2. Functional Characterization of PknI-Rv2159c Interaction in Redox Homeostasis of
Venkatesan A; Palaniyandi K; Sharma D; Bisht D; Narayanan S
Front Microbiol; 2016; 7():1654. PubMed ID: 27818650
[No Abstract] [Full Text] [Related]
3. Homology modelling, docking, pharmacophore and site directed mutagenesis analysis to identify the critical amino acid residue of PknI from Mycobacterium tuberculosis.
Kandasamy S; Hassan S; Gopalaswamy R; Narayanan S
J Mol Graph Model; 2014 Jul; 52():11-9. PubMed ID: 24955490
[TBL] [Abstract][Full Text] [Related]
4. The crystal structure of PknI from Mycobacterium tuberculosis shows an inactive, pseudokinase-like conformation.
Lisa MN; Wagner T; Alexandre M; Barilone N; Raynal B; Alzari PM; Bellinzoni M
FEBS J; 2017 Feb; 284(4):602-614. PubMed ID: 28054744
[TBL] [Abstract][Full Text] [Related]
5. Cloning, overexpression, and characterization of a serine/threonine protein kinase pknI from Mycobacterium tuberculosis H37Rv.
Gopalaswamy R; Narayanan PR; Narayanan S
Protein Expr Purif; 2004 Jul; 36(1):82-9. PubMed ID: 15177288
[TBL] [Abstract][Full Text] [Related]
6. Structural Insight into the Activation of PknI Kinase from M. tuberculosis via Dimerization of the Extracellular Sensor Domain.
Yan Q; Jiang D; Qian L; Zhang Q; Zhang W; Zhou W; Mi K; Guddat L; Yang H; Rao Z
Structure; 2017 Aug; 25(8):1286-1294.e4. PubMed ID: 28712808
[TBL] [Abstract][Full Text] [Related]
7. The serine/threonine protein kinase PknI controls the growth of Mycobacterium tuberculosis upon infection.
Gopalaswamy R; Narayanan S; Chen B; Jacobs WR; Av-Gay Y
FEMS Microbiol Lett; 2009 Jun; 295(1):23-9. PubMed ID: 19341393
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of hypothetical proteins of Mycobacterium tuberculosis with possible esterase/lipase signature: a cumulative in silico and in vitro approach.
Kumar A; Sharma A; Kaur G; Makkar P; Kaur J
J Biomol Struct Dyn; 2017 May; 35(6):1226-1243. PubMed ID: 27050490
[TBL] [Abstract][Full Text] [Related]
9. Protein-protein interaction of Rv0148 with Htdy and its predicted role towards drug resistance in Mycobacterium tuberculosis.
Bhargavi G; Hassan S; Balaji S; Tripathy SP; Palaniyandi K
BMC Microbiol; 2020 Apr; 20(1):93. PubMed ID: 32295519
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase I of Mycobacterium tuberculosis: cellular localization and expression during infection of macrophage-like cells.
Singh A; Singh Y; Pine R; Shi L; Chandra R; Drlica K
Tuberculosis (Edinb); 2006 Jan; 86(1):28-33. PubMed ID: 16256441
[TBL] [Abstract][Full Text] [Related]
11. Role of a Putative Alkylhydroperoxidase Rv2159c in the Oxidative Stress Response and Virulence of
Bhargavi G; Singh AK; Deenadayalan A; Ponnuraja C; Patil SA; Palaniyandi K
Pathogens; 2022 Jun; 11(6):. PubMed ID: 35745538
[No Abstract] [Full Text] [Related]
12. Mycobacterium tuberculosis serine/threonine protein kinases: structural information for the design of their specific ATP-competitive inhibitors.
Caballero J; Morales-Bayuelo A; Navarro-Retamal C
J Comput Aided Mol Des; 2018 Dec; 32(12):1315-1336. PubMed ID: 30367309
[TBL] [Abstract][Full Text] [Related]
13.
Gupta S; Shukla H; Kumar A; Shukla R; Kumari R; Tripathi T; Singh RK; Anupurba S
J Biomol Struct Dyn; 2020 Mar; 38(4):1083-1093. PubMed ID: 30898047
[TBL] [Abstract][Full Text] [Related]
14. Structure-based design of diverse inhibitors of Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase: combined molecular docking, dynamic simulation, and biological activity.
Soni V; Suryadevara P; Sriram D; ; Kumar S; Nandicoori VK; Yogeeswari P
J Mol Model; 2015 Jul; 21(7):174. PubMed ID: 26078037
[TBL] [Abstract][Full Text] [Related]
15. In-Silico Characterization of a Hypothetical Protein, Rv1288 of Mycobacterium tuberculosis Containing an Esterase Signature and an Uncommon LytE Domain.
Kumar A; Maan P; Singh G; Kaur J
Curr Comput Aided Drug Des; 2017; 13(2):101-111. PubMed ID: 27890013
[TBL] [Abstract][Full Text] [Related]
16. Double deletion of PknI/DacB2 leads to attenuation of Mycobacterium tuberculosis for growth and virulence.
Kandasamy S; Palaniyandi K; Gupta UD; Narayanan S
Tuberculosis (Edinb); 2020 Jul; 123():101957. PubMed ID: 32741534
[TBL] [Abstract][Full Text] [Related]
17. Probing the structure of Mycobacterium tuberculosis MbtA: model validation using molecular dynamics simulations and docking studies.
Maganti L; Open Source Drug Discovery Consortium ; Ghoshal N
J Biomol Struct Dyn; 2014; 32(2):273-88. PubMed ID: 23527569
[TBL] [Abstract][Full Text] [Related]
18. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.
Shen M; Zhou S; Li Y; Pan P; Zhang L; Hou T
Mol Biosyst; 2013 Mar; 9(3):361-74. PubMed ID: 23340525
[TBL] [Abstract][Full Text] [Related]
19. In silico characterization of binding mode of CCR8 inhibitor: homology modeling, docking and membrane based MD simulation study.
Gadhe CG; Balupuri A; Cho SJ
J Biomol Struct Dyn; 2015; 33(11):2491-510. PubMed ID: 25617117
[TBL] [Abstract][Full Text] [Related]
20. A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis.
Fakhar Z; Naiker S; Alves CN; Govender T; Maguire GE; Lameira J; Lamichhane G; Kruger HG; Honarparvar B
J Biomol Struct Dyn; 2016 Nov; 34(11):2399-417. PubMed ID: 26612108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
